National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
SU011248

 A drug used to treat gastrointestinal stromal tumors (GIST) that have not responded to treatment with imatinib mesylate (Gleevec). SU011248 is also used to treat advanced kidney cancer and is being studied in the treatment of other types of cancer. It is a type of tyrosine kinase inhibitor, a type of vascular endothelial growth factor (VEGF) receptor inhibitor, and a type of angiogenesis inhibitor. Also called SU11248, sunitinib, sunitinib malate, and Sutent.

Previous Definitions:strontium ranelate, strontium-89, study agent, Sturge-Weber syndrome, SU006668
Next Definitions:SU101, SU11248, SU5416, SU6668, subcutaneous